In re Impinj, Inc. Securities Litigation
|Court:||United States District Court, Western District of Washington|
|Judge:||Hon. Robert S. Lasnik|
|Class Period:||7/21/16 - 2/15/2018|
|Case Contacts:||Jonathan D. Uslaner, Michael D. Blatchley, Lauren M. Cruz|
This is a securities fraud class action filed on behalf of all purchasers of Impinj, Inc. (“Impinj” or the “Company”) common stock between July 21, 2016 and February 15, 2018, inclusive (the “Class Period”), alleging claims pursuant to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 against Impinj, a manufacturer of radio-frequency identification products used to manage inventory, and three of the Company’s senior executives.
The case, which was commenced by Employees’ Retirement System of the City of Baton Rouge and Parish of East Baton Rouge (“Baton Rouge”) on October 2, 2018, concerns Defendants’ alleged misrepresentations and omissions regarding the capabilities of and demand for Impinj’s product platform (“Platform”). The Complaint alleges Defendants falsely told investors that the Company’s Platform had the ability to accurately locate tagged items. The Complaint alleges that Defendants also falsely claimed that increased demand for the Platform was fueling its record revenue growth. According to the Complaint, the Platform suffered from poor location accuracy and demand for the Platform was declining during the Class Period. In response to Defendants’ statements, the price of Impinj’s shares traded at artificially-inflated levels, reaching a high of over $59 per share during the Class Period. When the truth emerged in a series of partial disclosures, the price declined to $11 per share.
On January 14, 2019, the Court appointed Baton Rouge as Lead Plaintiff for the Class and Bernstein Litowitz Berger and Grossmann LLP as Lead Counsel.
On February 13, 2019, Lead Plaintiff filed its consolidated class action complaint provisionally under seal.
Defendants moved to dismiss the Complaint, and Plaintiffs opposed their motion. On October 4, 2019, the Defendants’ motion to dismiss was largely denied by the Court.
Other Cases of Interest
Northern District of California, San Jose Division Jonathan D. Uslaner, Adam Hollander
Salix Pharmaceuticals, Ltd.
Southern District of New York Salvatore J. Graziano, John Rizio-Hamilton, Katherine M. Sinderson, Michael D. Blatchley, Adam Hollander
Restoration Hardware, Inc.
Northern District of California Jonathan D. Uslaner
Middle District of Florida Avi Josefson, Jonathan D. Uslaner
Karyopharm Therapeutics Inc.
District of Massachusetts Avi Josefson, Hannah Ross, Michael D. Blatchley, Scott R. Foglietta
JPMorgan Chase & Co.
Southern District of New York Avi Josefson, Salvatore J. Graziano, John Rizio-Hamilton, Jonathan D. Uslaner, Michael D. Blatchley, Jai K. Chandrasekhar
Southern District of New York Michael D. Blatchley
HeartWare International, Inc.
Southern District of New York John Rizio-Hamilton, Michael D. Blatchley, Abe Alexander, Julia Tebor
CTI Biopharma Corp.
Western District of Washington at Seattle Jonathan D. Uslaner
District of Delaware Hannah Ross, Avi Josefson, Michael D. Blatchley, Gregory V. Varallo